Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »
December 18, 2017

Top 25 Biopharma IPOs of 2017

First-Time Public Companies Find Smooth Sailing at Year’s End

Top 25 Biopharma IPOs of 2017

Biopharma companies that launched the top initial public offerings (IPOs) in 2017 found a receptive audience from investors, even in early stages of drug development, and were more than likely headquartered outside North America. [Prasit/Getty Images]

  • #14. Optinose

    Market (Symbol): NASDAQ Global Select Market (OPTN)

    Amount: Approximately $125.54 million in net proceeds 11

    Date: October 13

    Shares/Price per share: 8,625,000 shares at $16 11

  • #13. Rhythm Pharmaceuticals

    Market (Symbol): NASDAQ Global Market (RYTM)

    Amount: Approximately $125.8 million in net proceeds 12

    Date: October 5

    Shares/Price per share: 8,107,500 shares at $17 12

  • #12. Clementia Pharmaceuticals

    Market (Symbol): NASDAQ Global Select Market (CMTA)

    Amount: Approximately $128.2 million in net proceeds 13

    Date: August 2

    Shares/Price per share: 9.2 million shares at $15 13

  • #11. Erytech

    Market (Symbol): NASDAQ Global Select Market (ERYP) 14

    Amount: Approximately $130 million in aggregate net proceeds from “global” offering 14, 15

    Date: November 6

    Shares/Price per share: Up to 6,180,137 shares at $23.26 14, 15

  • #10. Akcea Therapeutics

    Market (Symbol): NASDAQ Global Select Market (AKCA)

    Amount: Approximately $132.4 million in net proceeds 16, 17

    Date: July 14

    Shares/Price per share: 17,968,750 shares at $8 16, 17

  • #9. Apellis Pharmaceuticals

    Market (Symbol): NASDAQ Global Select Market (APLS)

    Amount: Approximately $137.2 million in net proceeds 18

    Date: November 9

    Shares/Price per share: 10,714,000 shares at $14 18

  • #8. Zai Lab

    Market (Symbol): NASDAQ Global Market (ZLAB)

    Amount: Approximately $157.1 million in net proceeds 19

    Date: September 20

    Shares/Price per share: 9,583,333 American depositary shares at $18 19

  • #7. Tiansheng Pharmaceutical Group

    Market (Symbol): Shenzhen Stock Exchange: 002872

    Amount: RMB 1.079 billion ($163 million) in net proceeds

    Date: May 19

    Shares/Price per share: 53 million shares at RMB 22.37 ($3.39) 

  • #6. Biohaven Pharmaceuticals

    Market (Symbol): New York Stock Exchange (BHVN)

    Amount: $176.367 million in net proceeds 20

    Date: May 4

    Shares/Price per share: 11.385 million shares at $17 20

  • #5. Ablynx

    Market (Symbol): NASDAQ Global Select Market (ABLX) 21

    Amount: $210.2 million in aggregate net proceeds 22

    Date: October 30

    Shares/Price per share: 13,144,500 American Depositary Shares at $17.50 22

  • #4. Denali Therapeutics

    Market (Symbol): NASDAQ Global Select Market (DNLI)

    Amount: Approximately $229 million in net proceeds 23

    Date: December 8

    Shares/Price per share: 13,888,888 shares at $18 23

  • #3. Eris Lifesciences

    Market (Symbol): National Stock Exchange of India (ERIS)

    Amount: Rs. 17.41 billion ($269.9 million) in gross proceeds 24

    Date: June 16

    Shares/Price per share: 28.875 million shares at Rs. 600 to Rs. 603 ($9.28 to $9.33) 24

  • #2. WuXi Biologics

    Market (Symbol): Hong Kong (2269)

    Amount: Approximately HK$3.905 billion ($500.4 million) in net proceeds 25

    Date: June 13

    Shares/Price per share: 221,959,500 shares at HK$20.60 ($2.64) 25

  • #1. Celltrion

    Market (Symbol): KOSDAQ market of the Korea Stock Exchange (068270) 26

    Amount: KRW 1.009 trillion ($923.9 million)

    Date: July 28

    Shares/Price per share: 24,604,000 shares at KRW 41,000 ($37.78) 26

Related content